# EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care

> **NCT05254808** · PHASE3 · TERMINATED · sponsor: **MJM Bonten** · enrollment: 13 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DRUG:** Fosfomycin
- **DRUG:** Nitrofurantoin

## Key facts

- **NCT ID:** NCT05254808
- **Lead sponsor:** MJM Bonten
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-06
- **Primary completion:** 2022-02-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Insufficient participating sites, and insufficient participants from participating sites mainly due to COVID-19 workload. The number of necessary participants could not be reached within the anticipated timelines and the allocated budget.
- **Last updated:** 2022-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254808, "EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05254808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*